International Journal of Gynecologic Cancer: 30 (11)

Lead article

Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) (7 October, 2020) Free
Anna Fagotti, Maria Gabriella Ferrandina, Giuseppe Vizzielli, Tina Pasciuto, Francesco Fanfani, Valerio Gallotta, Pasquale Alessandro Margariti, Vito Chiantera, Barbara Costantini, Salvatore Gueli Alletti, Francesco Cosentino, Giovanni Scambia

Editorial

Neoadjuvant chemotherapy for advanced ovarian cancer: the tail of the scorpion for radical debulking surgery? (12 October, 2020) Free
Christina Fotopoulou

COVID-19

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective (8 October, 2020)
Irina Tsibulak, Elisabeth Reiser, Gerhard Bogner, Edgar Petru, Johanna Hell-Teutsch, Alexander Reinthaller, Cornelia Weirather, Tatjana Weiss, Szabolcs Bozsa, Barbara Puschacher, Mirijam Hall, Doris Hittler, Katharina Hrauda, Elisabeth Thell, Sabine Clauss, Johanna Pozniak, Sebastian Alicke, Daniela Gangl, Gottfried Gamperl, Christoph Ebner, Katharina Knoll, Katharina Leitner, Andrea Schilcher, Marina Schinnerl, Verena Sigl, Christian Singer, Thomas Aigmüller, Birgit Hofstätter, Christian Marth

Vulvar Cancer

Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva (30 September, 2020) Free
Michele Bartoletti, Roberta Mazzeo, Marco De Scordilli, Anna Del Fabro, Maria Grazia Vitale, Lucia Bortot, Milena Sabrina Nicoloso, Serena Corsetti, Marta Bonotto, Simona Scalone, Giorgio Giorda, Roberto Sorio, Claudia Andreetta, Maria Luisa Meacci, Rocco De Vivo, Gianpiero Fasola, Francesco Sopracordevole, Fabio Puglisi

Cervical Cancer

HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study (9 October, 2020)
Berit Andersen, Sisse Helle Njor, Anne Marie Schak Jensen, Tonje Johansen, Ulla Jeppesen, Hans Svanholm
Non-invasive stereotactic ablative boost in patients with locally advanced cervical cancer (6 July, 2020)
Shraddha Dalwadi, Alfredo Echeverria, Pavan Jhaveri, Tung Bui, Nabila Waheed, Danny Tran, Mark Bonnen, Michelle Ludwig
Prediction scoring system based on clinicohematologic parameters for cervical cancer patients undergoing chemoradiation (16 June, 2020)
Youn Ji Kim, Young Saing Kim, Jin Woo Shin, Biche Osong, Seok Ho Lee
Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review (30 August, 2020)
Alberto Ferreira Bona, Kamila Rodrigues Ferreira, Raquel Boechat de Moura Carvalho, Luiz Claudio Santos Thuler, Anke Bergmann
Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer (8 October, 2020)
Marjolein De Cuypere, Pierre Lovinfosse, Christine Gennigens, Johanne Hermesse, Ramon Rovira, Joan Duch, Frédéric Goffin, Roland Hustinx, Frédéric Kridelka

Uterine Cancer

Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study – a multicentric analysis of predictors of failed mapping (31 August, 2020)
Giulio Sozzi, Francesco Fanfani, Roberto Berretta, Vito Andrea Capozzi, Stefano Uccella, Natalina Buono, Vincenzo Giallombardo, Mariano Catello Di Donna, Giorgia Monterossi, Stefano Restaino, Ilaria Capasso, Giorgia Dinoi, Giovanni Scambia, Vito Chiantera
Cost-effectiveness of robotic hysterectomy versus abdominal hysterectomy in early endometrial cancer (30 August, 2020)
Evelyn Serreyn Lundin, Per Carlsson, Ninnie Borendal Wodlin, Lena Nilsson, Preben Kjölhede
Does iatrogenic tumor rupture during surgery have prognostic implications for the outcome of uterine sarcomas? (18 September, 2020)
Virginia Benito, Amina Lubrano, Laureano León, Fernando Molano, Beatriz Pinar
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer (5 October, 2020)
Brian M Slomovitz, Anca Chelariu-Raicu, Kathleen M Schmeler, Karen H Lu, David M Gershenson, Judith Wolf, Robert L Coleman
Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion (7 August, 2020)
Ji Son, Laura M Chambers, Caitlin Carr, Chad M Michener, Meng Yao, Anna Beavis, Ting-Tai Yen, Rebecca L Stone, Stephanie L Wethington, Amanda N Fader, Wesley C Burkett, Debra L Richardson, Allison S Staley, Susie Ahn, Paola A Gehrig, Diogo Torres, Sean C Dowdy, Mackenzie W Sullivan, Susan C Modesitt, Catherine Watson, Ashley Veade, Jessie Ehrisman, Laura Havrilesky, Angeles Alvarez Secord, Amy Loreen, Kaitlyn Griffin, Amanda Jackson, Akila Viswanathan, Stephanie Ricci

Ovarian Cancer

Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care (11 August, 2020)
Charles H Norell, John Butler, Rhonda Farrell, Alon Altman, James Bentley, Citadel J Cabasag, Paul A Cohen, Scott Fegan, Michael Fung-Kee-Fung, Charlie Gourley, Neville F Hacker, Louise Hanna, Claus Kim Høgdall, Gunnar Kristensen, Janice Kwon, Orla McNally, Gregg Nelson, Andy Nordin, Dearbhaile O'Donnell, Tine Schnack, Peter H Sykes, Ewa Zotow, Samantha Harrison
BRCA testing in women with high-grade serous ovarian cancer: gynecologic oncologist-initiated testing compared with genetics referral
(5 August, 2020) Free
Sabrina Piedimonte, Joanne Power, William D Foulkes, Evan Weber, Laura Palma, Alicia Schiavi, Enza Ambrosio, Rea Konci, Lucy Gilbert, Kris Jardon, Laurence Baret, Xing Zeng
Diagnostic accuracy of serum insulin-like growth factor-binding protein 2 for ovarian cancer (17 August, 2020)
Pande Kadek Aditya Prayudi, I Nyoman Gede Budiana, Putu Doster Mahayasa, I Gede Ngurah Harry Wijaya Surya, Anak Agung Gede Putra Wiradnyana, Ketut Suwiyoga
Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer (9 October, 2020)
Anca Chelariu-Raicu, Charles F Levenback, Brian M Slomovitz, Judith Wolf, Diane C Bodurka, John J Kavanagh, Christopher Morrison, David M Gershenson, Robert L Coleman
Base rate of ovarian cancer on algorithms in patients with a pelvic mass (21 July, 2020)
Anne Lone Denny Rolfsen, Alv A Dahl, Are Hugo Pripp, Anne Dørum
Low value of staging in detecting extraovarian occult metastasis in mucinous borderline ovarian tumors (14 September, 2020)
Hee-Jung Jung, Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam

Surgery

Physical activity trajectories following gynecological cancer: results from a prospective, longitudinal cohort study (29 July, 2020) Free
Steven Fleming, Tamara Jones, Monika Janda, Dimitrios Vagenas, Leigh Ward, Hildegard Reul-Hirche, Carolina Sandler, Andreas Obermair, Sandra Hayes
A systematic review and meta-analysis of sarcopenia as a prognostic factor in gynecological malignancy (2 August, 2020)
Emma R Allanson, Yang Peng, Angela Choi, Sandra Hayes, Monika Janda, Andreas Obermair
Comparison of surgical and pathological parameters after laparoscopic transperitoneal pelvic/para-aortic lymphadenectomies (9 October, 2020)
Anna Jacob, Andrea Plaikner, Achim Schneider, Giovanni Favero, Roberto Tozzi, Peter Mallmann, Christian Domröse, Peter Martus, Simone Marnitz, Jana Barinoff, Christhardt Kohler

Reviews

Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes (6 September, 2020)
Antonella Pietragalla, Martina Arcieri, Claudia Marchetti, Giovanni Scambia, Anna Fagotti
Improving response to progestin treatment of low-grade endometrial cancer (6 May, 2020)
Eva Baxter, Donal J Brennan, Jessica N McAlpine, Jennifer J Mueller, Frédéric Amant, Mignon D J M van Gent, David G Huntsman, Robert L Coleman, Shannon N Westin, Melinda S Yates, Camilla Krakstad, Michael A Quinn, Monika Janda, Andreas Obermair

Clinical trials

DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment (2 September, 2020)
Michelle McMullen, Katherine Karakasis, Bienvenu Loembe, Emma Dean, Graem Parr, Amit M Oza
Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010) (24 September, 2020)
Hua Tu, He Huang, Bingna Xian, Jibin Li, Ping Wang, Weidong Zhao, Xiaojun Chen, Xing Xie, Chunyan Wang, Beihua Kong, Jing Xiao, Ping Zhang, Jihong Liu

Case study

Management of low-grade serous ovarian neoplasm in the setting of fertility preservation (5 August, 2020) Free
Zibi Marchocki, Marjan Rouzbahman, Tanya Chawla, Taymaa May

Corners of the world

Advancing gynecologic oncology in Latin America through Project ECHO (9 June, 2020) Free
Melissa Lopez Varon, Ellen Baker, Erick Estuardo Estrada, Kathleen M Schmeler, Rene Pareja

Video articles

Orthotopic continent urinary diversion (the Budapest pouch) in 10 steps (12 August, 2020) Free
Mihai Emil Căpîlna, Laszlo Palfalvi, Laszlo Ungar, Alexandra Cozlea, Szilard Leo Kiss, Mihai Stanca
Tertiary cytoreductive surgery by laparoscopy in granulosa cell tumor recurrence (1 July, 2020) Free
Virginia García Pineda, Alicia Hernández, María Cabanes, Jaime Siegrist, Myriam Gracia, Ignacio Zapardiel
Laparoscopic complete resection of bulky precaval nodes by extraperitoneal approach in a patient with advanced endometrial cancer (21 June, 2020) Free
Ibon Jaunarena, Mikel Gorostidi, Ruben Ruiz, Cecilia Villalain, Paloma Cobas, Arantza Lekuona

Commentary

Effective approaches towards eliminating cervical cancer from low-and middle-income countries amid COVID-19 pandemic (14 September, 2020)
Md Sazedur Rahman, Murat Gultekin, Zohra S Lassi

Letters

More attention is needed for the corrigendum to the revised FIGO staging for carcinoma of the cervix uteri (14 September, 2020)
Ester P Olthof, Constantijne H Mom, Jacobus van der Velden
Tumor size in cervical cancer: an ongoing dilemma (21 September, 2020)
Gloria Salvo, Diego Odetto, Caty Saenz Perrotta, Florencia Noll, Myriam Perrotta, Rene Pareja, Alejandra Wernicke, Pedro T Ramirez

Main menu

Table of contents

November 2020 - Volume 30 - 11

Lead article

Editorial

COVID-19

Vulvar Cancer

Cervical Cancer

Uterine Cancer

Ovarian Cancer

Surgery

Reviews

Clinical trials

Case study

Corners of the world

Video articles

Commentary

Letters

Miscellaneous

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

November 2020 - Volume 30 - 11

Lead article

Editorial

COVID-19

Vulvar Cancer

Cervical Cancer

Uterine Cancer

Ovarian Cancer

Surgery

Reviews

Clinical trials

Case study

Corners of the world

Video articles

Commentary

Letters

Miscellaneous

Issue Information